documents: FDA-2020-N-1088-0001
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | agency_id | docket_id | title | document_type | subtype | posted_date | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2020-N-1088-0001 | FDA | FDA-2020-N-1088 | Microbiology Devices; Reclassification of Nucleic Acid-Based Hepatitis C Virus Ribonucleic Acid Assay Devices, To Be Renamed Nucleic Acid-Based Hepatitis C Virus Ribonucleic Acid Tests | Proposed Rule | Amendment | 2020-04-02T04:00:00Z | 2020 | 4 | 2020-04-02T04:00:00Z | 2020-06-02T03:59:59Z | 2020-06-03T01:00:43Z | 2020-06820 | 0 | 0 | 090000648448123b |
Links from other tables
- 1 row from regs_document_id in fr_regs_crossref